Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
BRIACELL THERAPEUTICS CORP has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $1,506,699 between 2023 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in PHILADELPHIA, Pennsylvania.
3 rounds · latest SBIR Phase II award (HHS), Aug 2025
Sign in to see 3 rounds.
Sign inSign in to see 1 investors.
Sign inBRIACELL THERAPEUTICS CORP has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for BRIACELL THERAPEUTICS CORP.
Add diversity data